Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
European Radiology
Published in: European Radiology 3/2020

01-03-2020 | Letter to the Editor

Reply to Letter to the Editor: How to document adverse reactions induced by gadolinium-based contrast agents? A plea for type A and type B reactions

Authors: Johannes Uhlig, Christian Lücke, Jens Bremerich, Matthias Gutberlet

Published in: European Radiology | Issue 3/2020

Login to get access

Excerpt

With great interest we have received the “Letter to the Editor” by Boehm and Lombardo regarding our recent paper on acute adverse events (AAE) in cardiac MR (CMR) with Gd-based contrast agents (GBCAs) from the ESCR MRCT Registry in 72,839 patients [1]. …
Literature
1.
Uhlig J, Lücke C, Vliegenthart R et al (2019) Acute adverse events in cardiac MR imaging with gadolinium-based contrast agents: results from the European Society of Cardiovascular Radiology (ESCR) MRCT Registry in 72,839 patients. Eur Radiol 29(7):3686–3695CrossRef
2.
Böhm I, Schild H (2008) Contrast-media-induced hypersensitivity or allergic/allergic-like reactions? Suggestion for a more appropriate use of the nomenclature. Eur J Clin Pharmacol 64(9):931–932CrossRef
3.
4.
Bruder O, Schneider S, Pilz G et al (2015) 2015 update on acute adverse reactions to gadolinium based contrast agents in cardiovascular MR. Large multi-national and multi-ethnical population experience with 37788 patients from the EuroCMR Registry. J Cardiovasc Magn Reson 17:58
5.
Almen T (1994) The etiology of contrast medium reactions. Invest Radiol 29(Suppl 1):S37–S45CrossRef
Metadata
Title
Reply to Letter to the Editor: How to document adverse reactions induced by gadolinium-based contrast agents? A plea for type A and type B reactions
Authors
Johannes Uhlig
Christian Lücke
Jens Bremerich
Matthias Gutberlet
Publication date
01-03-2020
Publisher
Springer Berlin Heidelberg
Published in
European Radiology / Issue 3/2020
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-019-06508-x

Other articles of this Issue 3/2020

European Radiology 3/2020 Go to the issue

Imaging Informatics and Artificial Intelligence

Multiparametric MRI and auto-fixed volume of interest-based radiomics signature for clinically significant peripheral zone prostate cancer

Nuclear Medicine

ZTE MR-based attenuation correction in brain FDG-PET/MR: performance in patients with cognitive impairment

Oncology

Percutaneous thermal ablation of subcapsular hepatocellular carcinomas: influence of tumor-surface contact and protrusion on therapeutic efficacy and safety

Head and Neck

In vivo comparison of MRI- and CBCT-based 3D cephalometric analysis: beginning of a non-ionizing diagnostic era in craniomaxillofacial imaging?

Editorial Comment

Making sense of the CT Urogram

Computed Tomography

Extracellular volume fraction determined by equilibrium contrast-enhanced dual-energy CT as a prognostic factor in patients with stage IV pancreatic ductal adenocarcinoma